RAPT THERAPEUTICS INC (RAPT) Forecast, Price Target & Analyst Ratings

NASDAQ:RAPT • US75382E2081

Current stock price

58.02 USD
+0.04 (+0.07%)
At close:
58.02 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RAPT THERAPEUTICS INC (RAPT).

Forecast Snapshot

Consensus Price Target

Price Target
$54.97
-5.26% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.79
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
70.59%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$54.97
Upside
-5.26%
From current price of $58.02 to mean target of $54.97, Based on 17 analyst forecasts
Low
$9.09
Median
$59.16
High
$73.50

Price Target Revisions

1 Month
0.00%
3 Months
-7.44%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for RAPT. The average price target is 54.97 USD. This implies a price decrease of -5.26% is expected in the next year compared to the current price of 58.02.
The average price target has been revised downward by 7.44% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RAPT Current Analyst RatingRAPT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

RAPT Historical Analyst RatingsRAPT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
70.59%
RAPT was analyzed by 17 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about RAPT.
In the previous month the buy percentage consensus was at a similar level.
RAPT was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-21Leerink PartnersDowngrade Outperform -> Market Perform
2026-01-21BarclaysDowngrade Overweight -> Equal-Weight
2026-01-20Clear StreetDowngrade Buy -> Hold
2026-01-20LifeSci CapitalDowngrade Outperform -> Market Perform
2026-01-20TD CowenDowngrade Buy -> Hold
2026-01-20Wells FargoDowngrade Overweight -> Equal-Weight
2026-01-20HC Wainwright & Co.Downgrade Buy -> Neutral
2025-12-18TD CowenInitiate Buy
2025-11-12JP MorganMaintains Overweight -> Overweight
2025-11-07BarclaysMaintains Overweight -> Overweight
2025-11-03Wells FargoMaintains Overweight -> Overweight
2025-10-27GuggenheimInitiate Buy
2025-10-27HC Wainwright & Co.Maintains Buy -> Buy
2025-10-21Clear StreetMaintains Buy -> Buy
2025-10-21BarclaysMaintains Overweight -> Overweight
2025-10-21Wells FargoMaintains Overweight -> Overweight
2025-10-20JP MorganUpgrade Neutral -> Overweight
2025-10-13BarclaysInitiate Overweight
2025-09-30Clear StreetMaintains Buy -> Buy
2025-09-26Leerink PartnersUpgrade Market Perform -> Outperform
2025-08-12UBSMaintains Neutral -> Neutral
2025-08-08Wells FargoMaintains Overweight -> Overweight
2025-07-30JP MorganUpgrade Underweight -> Neutral
2025-07-22LifeSci CapitalInitiate Outperform
2025-07-10HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.79
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
91.35%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-3.34%

Next Earnings Summary

RAPT is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.79 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RAPT revenue by date.RAPT revenue by date.
5.04M3.81M
-24.40%		1.53M
-59.84%
-100.00%		54.974M142.8M
159.76%		545.51M
282.01%		1.021B
87.16%
EBITDA
YoY % growth
RAPT ebitda by date.RAPT ebitda by date.
-52.09M
-23.14%		-68.21M
-30.95%		-84.75M
-24.25%		-129.458M
-48.49%		-105.091M
-7.11%		-81.6M
39.46%		-111.69M
-36.88%		-127.5M
-14.16%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
RAPT ebit by date.RAPT ebit by date.
-53.21M
-21.96%		-69.21M
-30.07%		-85.8M
-23.97%		-129.418M
-48.09%		-111.244M
-7.03%		-86.726M
36.23%		-116.492M
-34.32%		-168.219M
-44.40%		-235.314M
-39.89%		-346.007M
-47.04%		-361.252M
-4.41%		-371.949M
-2.96%		-58.181M
84.36%		305.01M
624.25%
Operating Margin
RAPT operating margin by date.RAPT operating margin by date.
-1,055.75%-1,816.54%-5,607.84%N/AN/AN/AN/AN/AN/AN/A-657.13%-260.47%-10.67%29.87%
EPS
YoY % growth
RAPT eps by date.RAPT eps by date.
-17.52
5.62%		-20.24
-15.53%		-20.64
-1.98%		-25.38
-17.83%		-16.81
-2.30%		-2.64
89.38%		-3.31
-25.23%		-4.04
-21.99%		-6.06
-50.13%		-8.46
-39.62%		-8.03
5.10%		-8.60
-7.12%		-5.36
37.72%		0.77
114.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.79
91.35%		-0.73
-14.52%		-0.79
-22.18%		-0.84
-28.68%		-0.92
-16.53%		-0.74
-1.59%		-0.81
-1.47%		-0.91
-8.54%		-1.01
-9.80%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-21.42M
59.78%		-22.471M
-18.19%		-21.247M
-11.50%		-25.092M
-34.28%		-27.795M
-29.76%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-27.757M
49.04%		-25.696M
-33.38%		-27.411M
-40.32%		-29.369M
-51.61%		-30.891M
-11.29%		-30.804M
-19.88%		-33.456M
-22.05%		-38.148M
-29.89%		-42.636M
-38.02%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RAPT Yearly Revenue VS EstimatesRAPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2030 2031 2032 2033 200M 400M 600M 800M 1B
RAPT Yearly EPS VS EstimatesRAPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20 -25

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.49%
EPS Next 5 Year
10.67%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-4.65%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

RAPT THERAPEUTICS INC / RAPT Forecast FAQ

Can you provide the average price target for RAPT THERAPEUTICS INC stock?

17 analysts have analysed RAPT and the average price target is 54.97 USD. This implies a price decrease of -5.26% is expected in the next year compared to the current price of 58.02.

Can you provide the upcoming earnings date for RAPT THERAPEUTICS INC?

RAPT THERAPEUTICS INC (RAPT) will report earnings on 2026-05-06.

Can you provide the consensus estimates for RAPT THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of RAPT THERAPEUTICS INC (RAPT) is -0.79 USD and the consensus revenue estimate is 0 USD.